Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Phenotyping and Systems Biology Approaches to Understanding Metabolic Syndrome and Fatty Liver Disease
Marc‐Emmanuel Dumas, James Kinross, Jeremy K. Nicholson
Gastroenterology (2013) Vol. 146, Iss. 1, pp. 46-62
Closed Access | Times Cited: 178

Showing 1-25 of 178 citing articles:

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 759
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles, José Manuel Fernández‐Real, Massimo Federici, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1070-1080
Open Access | Times Cited: 584
The contributory role of gut microbiota in cardiovascular disease
W.H. Wilson Tang, Stanley L. Hazen
Journal of Clinical Investigation (2014) Vol. 124, Iss. 10, pp. 4204-4211
Open Access | Times Cited: 582
Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health
Pamela Vernocchi, Federica Del Chierico, Lorenza Putignani
Frontiers in Microbiology (2016) Vol. 7
Open Access | Times Cited: 357
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril, Kenneth Cusi
Diabetes Care (2017) Vol. 40, Iss. 3, pp. 419-430
Open Access | Times Cited: 312
Functional metabolomics: from biomarker discovery to metabolome reprogramming
Bo Peng, Hui Li, Xuan‐xian Peng
Protein & Cell (2015) Vol. 6, Iss. 9, pp. 628-637
Open Access | Times Cited: 293
Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis
Karin Jepsen, Søren Jepsen
Periodontology 2000 (2016) Vol. 71, Iss. 1, pp. 82-112
Closed Access | Times Cited: 271
Objective Set of Criteria for Optimization of Sample Preparation Procedures for Ultra-High Throughput Untargeted Blood Plasma Lipid Profiling by Ultra Performance Liquid Chromatography–Mass Spectrometry
Magali Sarafian, Mathieu Gaudin, Matthew R. Lewis, et al.
Analytical Chemistry (2014) Vol. 86, Iss. 12, pp. 5766-5774
Closed Access | Times Cited: 262
Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics
Ettje F. Tigchelaar, Alexandra Zhernakova, Jackie Dekens, et al.
BMJ Open (2015) Vol. 5, Iss. 8, pp. e006772-e006772
Open Access | Times Cited: 241
Plasma Trimethylamine N -Oxide, a Gut Microbe–Generated Phosphatidylcholine Metabolite, Is Associated With Atherosclerotic Burden
Vichai Senthong, Xinmin S. Li, Timothy Hudec, et al.
Journal of the American College of Cardiology (2016) Vol. 67, Iss. 22, pp. 2620-2628
Open Access | Times Cited: 215
Modules, networks and systems medicine for understanding disease and aiding diagnosis
Mika Gustafsson, Colm E. Nestor, Huan Zhang, et al.
Genome Medicine (2014) Vol. 6, Iss. 10
Open Access | Times Cited: 190
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic Background
Jinsheng Yu, Sharon Marsh, Junbo Hu, et al.
Gastroenterology Research and Practice (2016) Vol. 2016, pp. 1-13
Open Access | Times Cited: 185
The Gut Microbiota and Its Implication in the Development of Atherosclerosis and Related Cardiovascular Diseases
Estefania Sánchez-Rodríguez, Alejandro Egea-Zorrilla, Julio Plaza‐Díaz, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 605-605
Open Access | Times Cited: 170
The Coming of Age of AI/ML in Drug Discovery, Development, Clinical Testing, and Manufacturing: The FDA Perspectives
Sarfaraz K. Niazi
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2691-2725
Open Access | Times Cited: 44
Personal model‐assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD
Adil Mardinoğlu, Elias Björnson, Cheng Zhang, et al.
Molecular Systems Biology (2017) Vol. 13, Iss. 3
Open Access | Times Cited: 162
Early Prediction of Developing Type 2 Diabetes by Plasma Acylcarnitines: A Population-Based Study
Liang Sun, Liming Liang, Xianfu Gao, et al.
Diabetes Care (2016) Vol. 39, Iss. 9, pp. 1563-1570
Open Access | Times Cited: 150
Metabolomics technology and bioinformatics for precision medicine
Rajeev K. Azad, Vladimir Shulaev
Briefings in Bioinformatics (2017) Vol. 20, Iss. 6, pp. 1957-1971
Open Access | Times Cited: 140
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance
Kuen‐Cheh Yang, Hui‐Fang Hung, Chia‐Wen Lu, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 128
The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions
Shahla Abdollahi‐Roodsaz, Steven B. Abramson, Jose U. Scher
Nature Reviews Rheumatology (2016) Vol. 12, Iss. 8, pp. 446-455
Closed Access | Times Cited: 128
Systems biology in hepatology: approaches and applications
Adil Mardinoğlu, Jan Borén, Ulf Smith, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 6, pp. 365-377
Closed Access | Times Cited: 117
TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function
Eke G. Gruppen, Erwin Garcia, Margery A. Connelly, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 114
Magnetic Resonance Spectroscopy: Principles and Techniques: Lessons for Clinicians
Joshua M. Tognarelli, Mahvish Dawood, Mohamed Shariff, et al.
Journal of Clinical and Experimental Hepatology (2015) Vol. 5, Iss. 4, pp. 320-328
Open Access | Times Cited: 103
The genetic architecture of NAFLD among inbred strains of mice
Simon T. Hui, Brian W. Parks, Elin Org, et al.
eLife (2015) Vol. 4
Open Access | Times Cited: 100
Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function
Alexander Lercher, Anannya Bhattacharya, Alexandra Popa, et al.
Immunity (2019) Vol. 51, Iss. 6, pp. 1074-1087.e9
Open Access | Times Cited: 95
Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance
Marc‐Emmanuel Dumas, Alice Rothwell, Lesley Hoyles, et al.
Cell Reports (2017) Vol. 20, Iss. 1, pp. 136-148
Open Access | Times Cited: 91
Page 1 - Next Page

Scroll to top